Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.

@article{Berger2013HemorrhagicCI,
  title={Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.},
  author={Russell Evan Berger and Steven D. Salhanick and Maureen R Chase and Michael Ganetsky},
  journal={Annals of emergency medicine},
  year={2013},
  volume={61 4},
  pages={
          475-9
        }
}
STUDY OBJECTIVE Dabigatran is a reversible direct thrombin inhibitor recently approved for stroke prevention in patients with atrial fibrillation. An increasing number of patients receiving dabigatran present to the emergency department (ED) with bleeding complications. Unlike vitamin K antagonists, there are no accepted reversal agents for dabigatran and the data on course and management of bleeding complications are limited. The study objective is to describe the course of bleeding… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 9 times. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 26 CITATIONS, ESTIMATED 47% COVERAGE

55 Citations

01020'14'16'18
Citations per Year
Semantic Scholar estimates that this publication has 55 citations based on the available data.

See our FAQ for additional information.

Similar Papers

Loading similar papers…